Comparison of adipose tissue changes following administration of rosiglitazone in the dog and rat.
about
Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes.Rosiglitazone-induced mitochondrial biogenesis in white adipose tissue is independent of peroxisome proliferator-activated receptor γ coactivator-1αOM2, a Novel Oligomannuronate-Chromium(III) Complex, Promotes Mitochondrial Biogenesis and Lipid Metabolism in 3T3-L1 Adipocytes via the AMPK-PGC1α PathwayEffect of rosiglitazone on insulin sensitivity and body composition in type 2 diabetic patients [corrected].Activation of PPAR gamma induces profound multilocularization of adipocytes in adult mouse white adipose tissues.Coordinate Transcriptomic and Metabolomic Effects of the Insulin Sensitizer Rosiglitazone on Fundamental Metabolic Pathways in Liver, Soleus Muscle, and Adipose Tissue in Diabetic db/db Mice.Multi-tissue, selective PPARγ modulation of insulin sensitivity and metabolic pathways in obese rats.Peroxisome proliferator activated receptor γ protein expression is asymmetrically distributed in primary lung tumor and metastatic to lung osteosarcoma samples and does not correlate with gene methylation.Lack of "immunological fitness" during fasting in metabolically challenged animals.The adipose organ at a glanceBiomarkers of browning of white adipose tissue and their regulation during exercise- and diet-induced weight loss.The adipose organ: white-brown adipocyte plasticity and metabolic inflammation.Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone.Reduced expression of FOXC2 and brown adipogenic genes in human subjects with insulin resistance.Rosiglitazone increases fatty acid oxidation and fatty acid translocase (FAT/CD36) but not carnitine palmitoyltransferase I in rat muscle mitochondria.Rodent carcinogenicity profile of the antidiabetic dual PPAR alpha and gamma agonist muraglitazar.
P2860
Q24535742-83A9B044-018C-4465-84F7-033309F33455Q27314648-E1D529AC-2862-4D3B-9C7D-A9437BC9D5CBQ28546556-247E7E4B-9D81-442F-BB3B-D2C494B627D4Q30738419-086B868E-F0A0-45A3-8100-E00B01D78E80Q33575775-631E1F43-FB2E-403F-8C39-139BF46975C5Q34191246-AC11D84B-55ED-4712-9451-6CD44D463602Q34501727-3512D8D6-E0A7-4FD1-ABB9-513560239D64Q35763145-76D4DD9E-D878-488E-8E13-7DF7B092D663Q36020232-0D3D98F2-0BE4-4A6C-BA79-EA1307962D63Q36179944-091234EE-971F-441E-ABDD-47A44307DB9CQ37202429-5FAA27D6-1992-4AD8-83C4-74ABA604C42BQ38056234-3FC34D9A-C0BC-4357-A0E0-B1224223E1E5Q39698741-447B0D00-0667-4FAC-9565-5B565ADA5911Q42451614-71D31BB9-D3A7-4122-9D9C-224CC33C7B5AQ46779978-9709DE21-7CE5-46CD-8EB5-BE4C18603EACQ51757343-5C084C41-F876-4A93-A1CF-5AC6BF043561
P2860
Comparison of adipose tissue changes following administration of rosiglitazone in the dog and rat.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Comparison of adipose tissue c ...... iglitazone in the dog and rat.
@en
Comparison of adipose tissue c ...... iglitazone in the dog and rat.
@nl
type
label
Comparison of adipose tissue c ...... iglitazone in the dog and rat.
@en
Comparison of adipose tissue c ...... iglitazone in the dog and rat.
@nl
prefLabel
Comparison of adipose tissue c ...... iglitazone in the dog and rat.
@en
Comparison of adipose tissue c ...... iglitazone in the dog and rat.
@nl
P2093
P2860
P1476
Comparison of adipose tissue c ...... iglitazone in the dog and rat.
@en
P2093
P2860
P304
P356
10.1046/J.1463-1326.2001.00117.X
P577
2001-06-01T00:00:00Z